logo

Bellicum Pharmaceuticals, Inc (BLCM)



Trade BLCM now with
  Date
  Headline
5/2/2022 7:34:50 AM Bellicum Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/6/2021 7:36:59 AM Bellicum Pharma Announces Positive Interim Data From Phase 1/2 GoCAR-T Clinical Trials
9/1/2021 7:36:59 AM Bellicum And MD Anderson Announce Addl License Agreement For Use Of CaspaCIDe Safety Switch
6/28/2021 7:34:04 AM Bellicum Pharma Enters License Agreement With UNC Lineberger And Mass General For Use Of CaspaCIDe Safety Switch
1/28/2021 4:26:14 PM Bellicum Says FDA Lifted Clinical Hold On BPX-601 Phase 1/2 Clinical Trial